Drug Regulatory Authority of Bhutan

In order to control and regulate medicinal products in the Kingdom, the 81 session of the National Assembly passed The Medicines Act of the Kingdom of Bhutan, 2003 on 5th August 2003. Further, knowing that the medicine regulation demands the application of sound knowledge and skills and operates within a legal framework, Drug Regulatory Authority […]

» read more
Sensitization workshop on Pharmacovigilance and ADR reporting system in Bhutan (30th - 31st August 2016)
"targeting young and previously untrained medical doctors and nurses"
Annual Performance Agreement signing for 2016-17
Annual Performance Agreement signing for 2016-17
Please click on the slide to view the Newsletter.
Workshop for Pharmacy Store Keepers of Samtse Dzongkhag conducted on 29 and 30 April, 2016.
Pharmacovigilance Workshop for Healthcare Professionals. April 2 - 3, 2016
Signing of Technical Cooperation between Bhutan DRA and Thai FDA in the presence of WR, Bhutan Country office, Board members and DTAC members on 21 October 2015
Honorable Health Secretary addresses during the meeting of the Bhutan DRA and Thai FDA during the signing ceremony
Dr. Boonchai, Secretary General, Thai FDA, Ms Sukanya Jiarapong accompanied by Director of Bureau of Drug Control, Thai FDA and officials of Thai FDA, Ministry of Public Health visited Bhutan to sign the technical cooperation between Bhutan and Thai FDA. The signing of the technical cooperation has been of great success.
Our Thai FDA delegates during the leisure trip to Paro Taktshang

Announcements & Notifications

Amendment of section 16.6.6 of the BCSR 2012 – September 30, 2016

The current rules on mileage claims require that a civil servant or his/her spouse own a vehicle to make the claims to which they are entitled due to their position level.

» read more

Re-Notice Inviting Tender

Drug Regulatory Authority (DRA) is pleased to invite sealed quotation from the eligible suppliers with valid Bhutanese Trade License for the catering services for the financial year 2016-2017. Please click on the link below for more details.

» read more

Notification to the Market Authorization Holders

In order to allow smooth functioning of the Drug Regulatory Authority (DRA) with regard to the issuance of Import Authorization (IA) and to create convenience among the Market Authorization Holders (MAH) while applying for IA, the DRA would has made the following changes to the notification issued to the MAHs earlier vide notification no. 12/DRA/ADM/NTF/2014/1359, […]

» read more